Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition marked by breathlessness, chronic sputum production and cough, claiming three million lives globally each year —particularly in low-resource countries — and is expected to increase due to aging populations and ongoing exposure to risks like tobacco smoke.
Urgent action is needed, to prevent pneumonia deaths among high-risk groups, particularly children younger than five years and older people, noted the American Thoracic Society and its Forum of International Respiratory Societies (FIRS) partners. New effective preventive interventions are available, but these are still inaccessible in many low- and middle-income countries (LMICs).
The American Thoracic Society is accepting scientific abstracts and case report submissions for presentation at the ATS 2025 International Conference. Submissions on all aspects of respiratory disease, critical care medicine and sleep medicine will be considered and are due no later than 5 p.m. ET, Wednesday, Nov. 6, 2024.
Disruptions in manufacturing operations after Hurricanes Helene and Milton have significantly affected the supply of life-saving IV fluids, leaving some health systems in dire need. While some medical centers have stockpiles in place, others may need to ration their IV fluid supply and delay surgeries. The American Thoracic Society is providing tips to help hospitals mitigate supply chain impacts.
Systemic racism remains a significant challenge in efforts to address health disparities in childhood asthma. A new American Thoracic Society report provides practical frameworks to begin the research necessary to make real progress in treating asthma in Black and Latino children, who are more likely than their white counterparts to report to emergency rooms in the U.S.
Over 90 percent of people around the world are exposed to unhealthy air, according to the World Health Organization. In 2019, ambient air pollution was responsible for 4.2 million premature deaths. That’s roughly the number of people who visit Manhattan on a typical weekday.
We are excited to announce that the American Thoracic Society has achieved GuideStar Platinum Status. As a 501c3 non-profit organization, the ATS leverages donations to further its mission to accelerate global innovation to advance respiratory health through multidisciplinary collaboration, education and advocacy.
Asthma medications and treatment challenges have been top of mind more so than usual – think supply chain issues, medication discontinuations as well as insurance concerns.
Wildfire season is upon us and again communities in some parts of the U.S. and Canada are battling devastating fires that threaten the health of everyone, especially individuals with lung disease. According to the National Interagency fire Center, as of this morning, 75 large wildfires are being managed nationwide.
According to the World Health Organization, lung cancer kills more people yearly than breast, colon, and prostate cancers combined, and there are 2.1 million lung cancer cases worldwide. The risk of death can be drastically reduced through early detection of cancer and appropriate treatment.
American Thoracic Society Environmental Health Policy Committee Chair Alison Lee, MD, strongly opposes proposed FY25 cuts that would jeopardize the health of all Americans: “Clean air, clean water and a healthy environment are essential to the health of all Americans. That is why I am calling on Congress to scrap the current FY25 Interior and Environment Appropriations bill and start over.
In support of the third annual World Bronchiectasis Day, July 1, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is joining the COPD Foundation and several global organizations to raise awareness, share knowledge, and discuss ways to reduce the burden of bronchiectasis for patients and their families worldwide.
Despite initiatives around the world to reduce the use of tobacco products amongst young people, smoking is still prevalent in those aged 18 and under. On World No Tobacco Day May 31, the Forum of International Respiratory Societies (FIRS), is encouraging policy makers to take steps to prevent young people from taking up smoking.
Irina Petrache, MD, ATSF, today added president of the American Thoracic Society to her list of accomplishments. The announcement came on the heels of the Plenary Session at the ATS 2024 International Conference.
Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and allergy clinicians have not adopted this optimal therapy, according to research published at the ATS 2024 International Conference.
Pediatric Impact of COVID-19 and Other Respiratory Infections Clinical Prediction Tool for Prioritizing Respiratory Syncytial Virus Prevention Products for High-Risk Infants During Current Limited Availability of Nirsevimab in the United States
This week at the ATS 2024 International Conference, researchers announced results from three clinical trials – the ARISE Study on amikacin liposome inhalation suspension in adults with mycobacterium avium complex disease, Tezepelumab for moderate to very severe COPD (Phase 2A COURSE study), and dupilumab in patients with moderate to severe COPD (Phase 3 NOTUS trial).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right